1. Home
  2. Live Updates
  3. Institute of nuclear medicine allied sciences

Live Breaking News & Updates on Institute of nuclear medicine allied sciences

Stay informed with the latest breaking news from Institute of nuclear medicine allied sciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Institute of nuclear medicine allied sciences and stay connected to the pulse of your community

DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies

DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Ahmedabad , Gujarat , India , Delhi , Himachal-pradesh , Narendra-modi , Aatmanirbhar-bharat , Samirv-kamat , Defense-research-development-organisation , Scott-edil-pharmacia-ltd , World-health-organization , Skanttr-lifescience

Manufacturing of critical drug for radiological & nuclear emergencies gets DCGI approval

Prussian blue insoluble formulations developed by the industry on a DRDO technology

Ahmedabad , Gujarat , India , Delhi , Himachal-pradesh , Scott-edil-pharmacia , Institute-of-nuclear-medicine-allied-sciences , Skanttr-lifescience , Technology-development-fund , Defence-research-development-organisation , World-health-organisation

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Indian drug 2DG can reduce heart damage by coronavirus, find US researchers

Dr Reddy's Laboratories last year announced the commercial launch of 2-deoxy-D-glucose (2DG) for treatment of Covid-19. 2DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.Now,

Umsom , Ch-ungch-ong-namdo , South-korea , Hyderabad , Andhra-pradesh , India , Han , Institute-of-nuclear-medicine-allied-sciences , University-of-maryland-school-medicine , Communications-biology , Drug-administration

Indian drug 2DG can reduce heart damage by coronavirus, find US researchers

A team of US researchers has identified how a specific protein in coronavirus damages heart tissue and they used a drug, currently in emergency use for the treatment of Covid in India, to reverse the toxic effects of that protein on the ...

Umsom , Ch-ungch-ong-namdo , South-korea , Hyderabad , Andhra-pradesh , India , Han , Institute-of-nuclear-medicine-allied-sciences , University-of-maryland-school-medicine , Communications-biology , Drug-administration

Welcome To IANS Live - LatestNews - Indian drug 2DG can reduce heart damage by coronavirus, find US researchers

Dr Reddy's Laboratories last year announced the commercial launch of 2-deoxy-D-glucose (2DG) for treatment of Covid-19. 2DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.Now,

Umsom , Ch-ungch-ong-namdo , South-korea , Hyderabad , Andhra-pradesh , India , Han , Institute-of-nuclear-medicine-allied-sciences , University-of-maryland-school-medicine , Communications-biology , Drug-administration

அக்னிபத் திட்டத்தில் இணைந்தால் நன்மை! இளைஞர்களுக்கு முன்னாள் கமாண்டன்ட் அழைப்பு

அக்னிபத் திட்டத்தில் இணைந்தால் நன்மை! இளைஞர்களுக்கு முன்னாள் கமாண்டன்ட் அழைப்புAgnipath,அக்னிபத் - Dinamalar Tamil News

Hindustan , India-general- , India , Mazagon , Maharashtra , Dihar , Bihar , Dipas , Rajasthan , Bharat , Tata-vistara , Centre-for-energetic-materials

MSN Laboratories enters into licence agreement with DRDO for 2 DG

MSN Laboratories enters into licence agreement with DRDO for 2 DG
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

India , Defence-research-development-establishment , Union-health-ministry , Institute-of-nuclear-medicine-allied-sciences , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Development-establishment , Nuclear-medicine , Allied-sciences , Drug-controller-general

India's first indigenous anti-Covid-19 drug is a repurposed trial medicine for cancer

India's first indigenous anti-Covid-19 drug is a repurposed trial medicine for cancer
scroll.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scroll.in Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Shashank-joshi , Institute-of-nuclear-medicine-allied-sciences , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Clinical-trial-registry , Maharashtra-covid , Deccan-herald

2-DG: DRDO and Dr Reddy's drug for Covid-19 treatment in India — Quartz India

2-DG: DRDO and Dr Reddy's drug for Covid-19 treatment in India — Quartz India
qz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qz.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Reddy-covid , Shashank-joshi , Institute-of-nuclear-medicine-allied-sciences , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Clinical-trial-registry , Maharashtra-covid

Dr Reddys announces commercial launch of 2-DG


Dr Reddys Laboratories announced the commercial launch of 2-deoxy-D-glucose (2-DG).
Dr. Reddy's will supply to major Government as well as private hospitals across India. In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.
2-DG manufactured by Dr. Reddy's has a purity of 99.5% and is being sold commercially under the brand name 2DG.
The maximum retail price (MRP) of each sachet has been fixed at Rs. 990, with a subsidized
rate offered to Government institutions. Enquiries for 2DG can be sent to 2DG@drreddys.com.

India , Institute-of-nuclear-medicine-allied-sciences , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Capital-market , இந்தியா , நிறுவனம்-ஆஃப்-அணு-மருந்து-கூட்டணி-அறிவியல் , வளர்ச்சி-ஆர்கநைஸேஶந் , பாதுகாப்பு-ஆராய்ச்சி